Autoimmune Diseases D001327

Diseases [C] » Immune System Diseases [C20] » Autoimmune Diseases

Description

Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.   MeSH

Hierarchy View

Subtype Terms (29)

Addison Disease
10 drugs (7 approved, 3 experimental)

Anemia, Hemolytic, Autoimmune
36 drugs (25 approved, 11 experimental)

Anti-Glomerular Basement Membrane Disease
1 experimental drug

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
20 drugs (17 approved, 3 experimental)

Antiphospholipid Syndrome
22 drugs (17 approved, 5 experimental)

Arthritis, Juvenile
75 drugs (53 approved, 22 experimental)

Arthritis, Rheumatoid
530 drugs (211 approved, 319 experimental)

Autoimmune Diseases of the Nervous System
16 drugs (10 approved, 6 experimental)

Autoimmune Hypophysitis
 

Autoimmune Lymphoproliferative Syndrome
5 approved drugs

Autoimmune Pancreatitis
2 approved drugs

Birdshot Chorioretinopathy
2 approved drugs

Dermatitis Herpetiformis
9 drugs (7 approved, 2 experimental)

Diabetes Mellitus, Type 1
368 drugs (181 approved, 187 experimental)

Glomerulonephritis, IGA
63 drugs (34 approved, 29 experimental)

Glomerulonephritis, Membranous
30 drugs (20 approved, 10 experimental)

Graves Disease
29 drugs (19 approved, 10 experimental)

Hepatitis, Autoimmune
24 drugs (15 approved, 9 experimental)

Immunoglobulin G4-Related Disease
18 drugs (14 approved, 4 experimental)

Latent Autoimmune Diabetes in Adults
4 drugs (3 approved, 1 experimental)

Linear IgA Bullous Dermatosis
3 drugs (1 approved, 2 experimental)

Lupus Erythematosus, Systemic
240 drugs (117 approved, 123 experimental)

Ophthalmia, Sympathetic
3 approved drugs

Pemphigoid, Bullous
25 drugs (18 approved, 7 experimental)

Pemphigus
34 drugs (20 approved, 14 experimental)

Polyendocrinopathies, Autoimmune
 

Purpura, Thrombocytopenic, Idiopathic
79 drugs (53 approved, 26 experimental)

Thyroiditis, Autoimmune
8 drugs (5 approved, 3 experimental)

Undifferentiated Connective Tissue Diseases
4 approved drugs



Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.